Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,793.20
(
-1.41%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,143.35
(
-3.79%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

oldberkeley

Send PM Follow Ignore
Followers 58
Posts 5142
Boards Moderated 0
Alias Born 07/23/2007

oldberkeley

Re: surf1944 post# 63626

Saturday, 06/21/2008 1:25:08 PM

Saturday, June 21, 2008 1:25:08 PM

Post# of 257257
>The 200 DMA vs buyout price for biotechs will just not pan out...

You're probably right, I was just exploring a line of thought that was suggested by a post on the GTCB board.

I think we'd both agree with what Dew recently wrote:

The stock market can be notoriously inefficient, but the market for buying and selling drugs and drug companies is generally quite efficient.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now